Dr. Shao-Lee Lin discusses the new data presented at the EULAR 2019 that point to the systemic implications of uncontrolled gout & the need for treatment improvement.
Dr. Jonathan Cheng discusses the approval of KEYTRUDA as monotherapy for patients with metastatic small cell lung cancer.
Dr. Krishna Doniparthi, Director and physician at Functional Medicine of Georgia discusses brain health on behalf of BodyBio, a world leader in fatty acid research.
Dr. Martin Schreiber, Chief Medical Officer for DaVita Home Dialysis, discusses kidney disease and the advancements in home dialysis care.
Dr. Levine discusses the scientifically-based cannabis technologies as aid for sleep disorder and pain control.
Dr. Crystal discusses marijuana unintended medical consequences & a new medicine to counteract cannabis-related overdoses.
Dr. Crystal talks about why the opioid crisis has become a fentanyl crisis and an antidote to protect against a fentanyl attack.
Dr. Scharre discusses the mild cognitive impairment (MC) signs and the latest study being conducted at OSU, Cornell & Rockefeller Neuroscience Center.
Data from Farxiga Phase III DECLARE-TIMI 58 trial shows it significantly helped to reduce the progression of kidney disease in patients with type 2 diabetes.
Dr. Glenn Copeland, founder, chairman, and CEO of Copeland Biosciences discusses the company’s focus on nanotechnology to administer CBD (cannabidiol) in the treatment of sports injuries.